Author name: Medical Pharma Lifestyle Pulse

Dr. Geetika Joshi is a seasoned health writer with over a decade of experience in the pharmaceutical industry. With a deep understanding of medical science and a passion for clear communication, she is dedicated to translating complex health topics into accessible, evidence-based content. Motivated by the belief that knowledge is a powerful tool for well-being, Dr. Joshi founded a health blog that makes medical information relatable and easy to understand. Her writing bridges the gap between clinical expertise and everyday life, empowering readers to make informed decisions about their health.

Close-up image of rod-shaped bacteria under a microscope, showcasing microscopic detail.

Discovering Nafithromycin A Landmark Achievement as India’s First Indigenous Antibiotic

Nafithromycin is India’s first indigenous antibiotic and the first significant innovation in its antibiotic class in over 30 years. It represents a breakthrough in the fight against antibiotic resistance. We address a few questions regarding this milestone antibiotic, Nafithromycin, here.

Discovering Nafithromycin A Landmark Achievement as India’s First Indigenous Antibiotic Read Post »

Unrecognizable medical professional holding a syringe, ready for injection.

Tirzepatide- New Hope for Diabetes and Obesity in India?

Obesity and diabetes are becoming increasingly prevalent worldwide. India has the second-highest number of people with diabetes and the third-highest percentage of obese people. As a result, advanced and novel therapeutic options are required. Tirzepatide is a new drug approved in many countries globally as a once-weekly subcutaneous injectable for type 2 diabetes and obesity. India’s drug regulator, CDSCO, recently approved its marketing nationwide. Herein, we present a brief overview of the key characteristics of Tirzepatide, its advantages, and shortcomings.

Tirzepatide- New Hope for Diabetes and Obesity in India? Read Post »

error
Scroll to Top
Verified by MonsterInsights